Prestige BioPharma Limited
KSE:950210.KS
18000 (KRW) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||||||
| Nettowinst
| -13,055.824 | -1,447.792 | -13,027.978 | -17,032.206 | -15,333.113 | -22,138.633 | -19,014.857 | 53,627.837 | -101,309.789 | -85,958.054 | -14,011.632 | -10,170.662 | 2,581.8 | -9,707.58 | 135.516 | -400.672 | -6,788.282 |
| Afschrijvingen & Amortisatie
| 0 | 4,478.792 | 3,841.792 | 3,414.928 | 3,415.647 | 3,263.992 | 3,146.931 | 1,800.186 | 1,181.812 | 955.456 | 964.046 | 782.583 | 539.794 | 0 | 0 | 0 | 520.934 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11,445.573 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 368.688 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,320.585 | 0 | 0 | 0 | -9,884.741 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 931.884 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,014.317 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,264.542 | 0 | 0 | 0 | 0 |
| Overige Niet-Contante Posten
| -8,570.737 | -4,928.479 | -2,336.091 | 1,339.294 | -12,875.91 | 16,809.893 | -2,221.323 | -70,754.636 | 89,136.367 | 60,280.409 | 1,025.355 | 13,918.938 | 398.524 | 10,701.755 | -9,908.873 | 2,610.803 | 4,473.716 |
| Kasstroom uit Operationele Activiteiten
| -13,420.76 | -10,855.063 | -11,522.276 | -12,277.984 | -24,793.376 | -2,064.748 | -18,089.249 | -15,326.613 | -10,991.61 | -25,677.645 | -12,986.277 | 3,748.276 | -8,877.352 | 994.175 | -9,773.357 | 2,210.131 | -11,678.373 |
| Investeringsactiviteiten: | |||||||||||||||||
| Investeringen in Materiële Vaste Activa
| -6,723.277 | -6,925.631 | -6,237.368 | -8,074.221 | -8,911.821 | -23,113.946 | -19,635.718 | -13,955.197 | -14,184.835 | -10,333.325 | -22,455.856 | -21,138.619 | -3,114.48 | -5,138.716 | -3,291.007 | -6,567.233 | -727.701 |
| Netto Overnames
| 0 | -0.469 | -18.173 | 69.943 | -72.984 | -35.558 | 316.742 | 39,830.402 | 9,671.77 | 16,816.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | -0 | -69.943 | -133,690.599 | 0 | 0 | 0 | -412.086 | -20,714.171 | -2,040.97 | -2,072.189 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 23,026.164 | 301.267 | 134,822.135 | 1,722.688 | 133,690.599 | 0 | 0 | 0 | -9,671.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -15.03 | 21.167 | 2,733.766 | -2,591.889 | -124,765.105 | 958.638 | 499.733 | 274.562 | 15,337.924 | -76,023.128 | -23,975.765 | -14,051.688 | -2,963.281 | -757.617 | 1,034.766 | -114.79 | 2,205.041 |
| Kasstroom uit Investeringsactiviteiten
| 16,729.555 | -6,603.667 | 131,300.359 | -8,943.422 | -133,749.91 | -22,190.866 | -18,819.243 | 26,149.767 | 741.003 | -107,070.624 | -45,459.552 | -32,896.077 | -6,077.761 | -5,896.333 | -2,256.241 | -6,682.023 | 1,477.34 |
| Financieringsactiviteiten: | |||||||||||||||||
| Schuldaflossingen
| -2.13 | -269.989 | -3,167.757 | -2,612.686 | -65.969 | -271.289 | -268.447 | -270.309 | -47.591 | -26.671 | -34.247 | -2,874.808 | -428.437 | -436.048 | -14.968 | -509.892 | 0 |
| Uitgifte van Gewone Aandelen
| -4.908 | 874.36 | 436.466 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,576.449 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -501.239 | 0 | -480.743 | 4,741.611 | 10,577.405 | 44,302.72 | -429.149 | -391.584 | -431.847 | -409.616 | -482.487 | -264.733 | -10,782.12 | 452,293.531 | -82.328 | -99.634 | -1,557.858 |
| Kasstroom uit Financieringsactiviteiten
| -504.017 | 119.955 | -3,212.034 | 2,128.925 | 10,511.436 | 44,031.431 | -697.596 | -661.893 | -479.438 | -436.287 | -448.24 | -3,139.541 | 3,365.892 | 451,857.483 | -97.296 | -609.526 | -1,557.858 |
| Overige Informatie: | |||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 1,678.684 | -2,030.102 | 2,134.535 | -1,174.394 | 1,835.549 | -3,164.357 | 8,298.638 | -81.553 | -718.491 | -43.579 | -1,608.948 | -805.549 | 8,043.334 | -8,670.291 | 59.605 | 289.809 | 82.178 |
| Netto Kasstroomverandering
| 5,674.826 | -22,669.022 | 1,617.667 | -20,266.875 | -146,697.072 | 11,605.821 | -27,096.574 | 10,079.708 | -3,483.49 | -128,764.297 | -55,174.031 | -33,092.891 | -3,453.604 | 437,513.465 | -13,403.268 | -4,791.609 | -11,905.897 |
| Kaspositie aan het Einde van de Periode
| 210,483.422 | 41,389.925 | 64,058.947 | 104,578.895 | 125,909.523 | 272,606.595 | 261,000.774 | 288,097.348 | 249,569.236 | 253,052.726 | 381,817.023 | 436,991.054 | 461,375.603 | 464,829.207 | 27,315.742 | 40,719.01 | 45,783.636 |